Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-27 Purchase |
2025-01-29 6:13 pm |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Manuf, Strategy&Bus Dev. |
30,000 | $5.24 | $157,200 | 693,555 (Indirect Direct) |
View |
| 2020-07-14 Purchase |
2020-07-15 5:00 pm |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
10,000 | $16 | $160,000 | 9,198,125 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-19 5:54 pm |
N/A N/A |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Manuf, Strategy&Bus Dev. |
15,817 | $0 | 634,372 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 6:13 pm |
N/A 2035-01-26 |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Manuf, Strategy&Bus Dev. |
87,500 | $0 | 693,555 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:17 pm |
N/A 2034-02-11 |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean CHIEF FINANCIAL OFFICER |
139,144 | $0 | 681,055 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 5:46 pm |
N/A 2034-01-23 |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean CHIEF FINANCIAL OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-14 7:21 pm |
N/A 2033-08-10 |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Financial Officer |
62,500 | $0 | 62,500 (Direct) |
View |
Ownership |
2023-08-14 7:19 pm |
N/A N/A |
TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Financial Officer |
0 | $0 | 714,092 (Indirect) |
View |
| 2022-08-15 Equity Swap |
2022-08-15 4:14 pm |
N/A N/A |
Radius Health Inc. | RDUS | Murphy Sean Director |
5,500 | $10 | 0 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-25 4:30 pm |
N/A 2032-01-14 |
Radius Health Inc. | RDUS | Murphy Sean Director |
15,500 | $0 | 21,000 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-23 5:58 pm |
N/A 2031-02-22 |
Radius Health Inc. | RDUS | Murphy Sean Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 5:13 pm |
N/A 2031-01-21 |
Radius Health Inc. | RDUS | Murphy Sean Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-10 Option Award |
2020-08-12 4:33 pm |
N/A 2030-08-10 |
Radius Health Inc. | RDUS | Murphy Sean Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-07-14 Conversion |
2020-07-15 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
20,645,718 | $0 | 9,198,125 (Indirect) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Murphy Sean Director 10% Owner |
0 | $0 | 9,188,125 (Indirect) |
View |